ABCL
Price
$2.60
Change
+$0.07 (+2.77%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
774.77M
13 days until earnings call
CBUS
Price
$2.00
Change
+$0.13 (+6.95%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
64.95M
Ad is loading...

ABCL vs CBUS

Header iconABCL vs CBUS Comparison
Open Charts ABCL vs CBUSBanner chart's image
AbCellera Biologics
Price$2.60
Change+$0.07 (+2.77%)
Volume$23.06K
Capitalization774.77M
Cibus
Price$2.00
Change+$0.13 (+6.95%)
Volume$1.31K
Capitalization64.95M
ABCL vs CBUS Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CBUS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and CBUS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ABCL: $2.60 vs. CBUS: $1.87)
Brand notoriety: ABCL and CBUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 87% vs. CBUS: 149%
Market capitalization -- ABCL: $774.77M vs. CBUS: $64.3M
ABCL [@Biotechnology] is valued at $774.77M. CBUS’s [@Biotechnology] market capitalization is $64.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCBUS’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CBUS’s FA Score: 1 green, 4 red.
According to our system of comparison, ABCL is a better buy in the long-term than CBUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while CBUS’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • CBUS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than CBUS.

Price Growth

ABCL (@Biotechnology) experienced а +7.44% price change this week, while CBUS (@Biotechnology) price change was +16.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

CBUS is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($775M) has a higher market cap than CBUS($65M). ABCL YTD gains are higher at: -13.311 vs. CBUS (-32.734). ABCL has higher annual earnings (EBITDA): -204.15M vs. CBUS (-492.98M). ABCL has more cash in the bank: 626M vs. CBUS (28.8M). CBUS has less debt than ABCL: CBUS (36.7M) vs ABCL (65.4M). ABCL has higher revenues than CBUS: ABCL (28.8M) vs CBUS (4.15M).
ABCLCBUSABCL / CBUS
Capitalization775M65M1,192%
EBITDA-204.15M-492.98M41%
Gain YTD-13.311-32.73441%
P/E RatioN/AN/A-
Revenue28.8M4.15M693%
Total Cash626M28.8M2,174%
Total Debt65.4M36.7M178%
FUNDAMENTALS RATINGS
CBUS: Fundamental Ratings
CBUS
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCBUS
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNST31.112.48
+8.66%
Renasant Corp
RTX120.286.53
+5.74%
RTX Corp
NYT50.440.32
+0.64%
New York Times Co
RMR14.62-0.04
-0.27%
RMR Group (The)
ADVM2.85-0.11
-3.72%
Adverum Biotechnologies

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+0.79%
CRSP - ABCL
62%
Loosely correlated
-1.76%
NTLA - ABCL
59%
Loosely correlated
-2.65%
ABSI - ABCL
57%
Loosely correlated
-0.47%
BEAM - ABCL
57%
Loosely correlated
+3.87%
RXRX - ABCL
57%
Loosely correlated
-0.89%
More

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with ABOS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
-5.08%
ABOS - CBUS
39%
Loosely correlated
+3.86%
CRBU - CBUS
38%
Loosely correlated
+0.79%
FHTX - CBUS
37%
Loosely correlated
+10.38%
NUVB - CBUS
37%
Loosely correlated
+0.97%
ABCL - CBUS
37%
Loosely correlated
+0.79%
More